Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Baxalta now part of Shire
With
Baxalta Innovations GmbH, now part of Shire
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult participant (or legal representative) is willing to provide informed consent
Participant is being treated or was treated (treatment initiation within 30 days) with Obizur in routine clinical practice
You may not be if
Participant has known anaphylactic reactions to the active substance, hamster protein or to any of the following excipients: Polysorbate 80; sodium chloride; calcium chloride dihydrate; sucrose; Tris Base; Tris HCl; Tri-sodium citrate dihydrate; sterilized water for injections
Participant has participated in a clinical study involving a medicinal product or device within 30 days prior to enrollment or is scheduled to participate in another clinical study involving a medicinal product or device at study entry
Clareo Health | Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice
